ATE617T1 - Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays. - Google Patents

Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays.

Info

Publication number
ATE617T1
ATE617T1 AT79101578T AT79101578T ATE617T1 AT E617 T1 ATE617 T1 AT E617T1 AT 79101578 T AT79101578 T AT 79101578T AT 79101578 T AT79101578 T AT 79101578T AT E617 T1 ATE617 T1 AT E617T1
Authority
AT
Austria
Prior art keywords
radioimmunoassays
steroid
processes
production
application
Prior art date
Application number
AT79101578T
Other languages
English (en)
Inventor
Ravi K. Varma
Sam T. Chao
Original Assignee
E.R. Squibb & Sons, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E.R. Squibb & Sons, Inc. filed Critical E.R. Squibb & Sons, Inc.
Application granted granted Critical
Publication of ATE617T1 publication Critical patent/ATE617T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Steroid Compounds (AREA)
AT79101578T 1978-05-22 1979-05-22 Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays. ATE617T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/908,294 US4323511A (en) 1978-05-22 1978-05-22 Steroid derivatives and their use in radioimmunoassays
EP79101578A EP0005558B1 (de) 1978-05-22 1979-05-22 Steroidderivate, Verfahren zu ihrer Herstellung und ihre Anwendung bei Radioimmunoassays

Publications (1)

Publication Number Publication Date
ATE617T1 true ATE617T1 (de) 1982-02-15

Family

ID=25425538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101578T ATE617T1 (de) 1978-05-22 1979-05-22 Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays.

Country Status (9)

Country Link
US (1) US4323511A (de)
EP (1) EP0005558B1 (de)
JP (1) JPS54151959A (de)
AT (1) ATE617T1 (de)
AU (1) AU523079B2 (de)
CA (1) CA1142915A (de)
DE (1) DE2961949D1 (de)
IL (1) IL57303A0 (de)
ZA (1) ZA791923B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243608A (en) * 1979-05-14 1981-01-06 E. R. Squibb & Sons, Inc. 3-(4-Hydroxyphenyl)pentanedioic acid, monohydrazide, derivatives and analogs
FR2537586A1 (fr) * 1982-12-13 1984-06-15 Roussel Uclaf Derives estratrieniques radioactifs marques a l'iode, leur procede de preparation et leur application aux dosages radio-immunologiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1118409A (en) * 1977-08-12 1982-02-16 Jack Bernstein Steroid derivatives and their use in radioimmunoassays

Also Published As

Publication number Publication date
CA1142915A (en) 1983-03-15
AU4641479A (en) 1979-11-29
JPS54151959A (en) 1979-11-29
IL57303A0 (en) 1979-09-30
EP0005558A1 (de) 1979-11-28
EP0005558B1 (de) 1982-01-27
DE2961949D1 (en) 1982-03-11
US4323511A (en) 1982-04-06
ZA791923B (en) 1980-04-30
AU523079B2 (en) 1982-07-08

Similar Documents

Publication Publication Date Title
ATE295T1 (de) Vitamin b12 derivate, verfahren zu deren herstellung und ihre verwendung bei radioimmun-testen.
KR830001868A (ko) 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
DE3367774D1 (de) 5,6,7-trinor-4, 8-inter-m-phenylene prostaglandin i2 derivatives
KR890003753A (ko) 에테르
IL56288A (en) 15-deoxy-16-hydroxy-2-decarboxy-2-hydroxymethylprostaglandin derivatives and their preparation
ES508735A0 (es) "procedimiento para la preparacion de derivados de (2-halogeno-ergolinil)-n',n'-dietilurea".
GB2002385A (en) Steroid hemiesters and their use in radioimmunoassays
ATE617T1 (de) Steroidderivate, verfahren zu ihrer herstellung und ihre anwendung bei radioimmunoassays.
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
CS715486A2 (en) Zpusob vyroby novych 1,2 disubstituovanych derivatu ergolinu
SE7713704L (sv) Propionsyraderivat och sett for framstellning av desamma
PT77208B (de) Neue thieno-thieno-derivate verfahren zu ihrer herstellung und diese verbindugen enthaltende
KR890006640A (ko) 항불안성인 r-n-(1-아자비시클로[2.2.2]옥트-3-일)벤즈아미드 및 티오벤즈아미드
ATE34752T1 (de) Mit tritium radioaktiv markierte estradienderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung und ihre anwendung zum studium und zur bestimmung von steroiden in biologischen fluessigkeiten.
GB2003480A (en) Digoxigenin derivatives
SE7811761L (sv) 4,5,6,7-tetrahydroimidazo-(4,5-c),pyridinderivat och forfarande for deras framstellning
ATE44742T1 (de) Verfahren zur herstellung von ergoline n-methyl- derivaten.
ES470892A1 (es) Procedimiento para la preparacion de nuevos n-bencil-aminoa-cidos que contienen azufre
KR850004471A (ko) 유기 화합물의 제조방법
GB1536195A (en) 3-phenyl-sec-butylamine derivatives
SE7901316L (sv) Derivat av dehydrocykliciminsyror
KR900003171A (ko) 방사성요오드화 벤조디아제핀 유도체
ES460297A1 (es) Un compuesto.
KR870003047A (ko) 벤조산 유도체의 제조방법
KR830005181A (ko) 아세트 아닐리드 유도체의 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee